000275650 001__ 275650
000275650 005__ 20240229154944.0
000275650 0247_ $$2doi$$a10.1186/s12944-023-01821-3
000275650 0247_ $$2pmid$$apmid:37106418
000275650 037__ $$aDKFZ-2023-00838
000275650 041__ $$aEnglish
000275650 082__ $$a570
000275650 1001_ $$aMekonnen, Daniel$$b0
000275650 245__ $$aComparative serum lipid and immunohematological values among adult pulmonary tuberculosis and tuberculosis lymphadenitis cases and their association with sputum bacilli load and time to culture positivity in Northwestern Ethiopia.
000275650 260__ $$aLondon$$bBiomed Central$$c2023
000275650 3367_ $$2DRIVER$$aarticle
000275650 3367_ $$2DataCite$$aOutput Types/Journal article
000275650 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1682672769_9445
000275650 3367_ $$2BibTeX$$aARTICLE
000275650 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000275650 3367_ $$00$$2EndNote$$aJournal Article
000275650 520__ $$aThe serum lipid and immunohematological values of tuberculosis lymphadenitis (TBLN) patients is poorly documented relative to pulmonary tuberculosis (PTB) cases. Therefore, the aim of this study was to investigate the serum lipid and immunohematological values of patients with TBLN in comparison with PTB (PTB) patients.An institution-based comparative cross-sectional study was conducted in Northwest Ethiopia from March to December 2021. The study participants were bacteriologically confirmed PTB (n = 82) and TBLN (n = 94) cases with no known comorbidity and whose ages was greater than 18 years and with no current pregnancy. Independent sample t-test, one-way ANOVA, box plot, and correlation matrix were used to analyze the data.The body mass index (BMI), CD4 + T cell count, and high-density lipoprotein-Cholesterol (HDL-C) values were significantly higher among TBLN cases compared with PTB cases. Additionally, the total white blood cell (WBC) count, hemoglobin (Hb), total Cholesterol (CHO) and creatinine (Cr) values were relatively higher among TBLN than PTB (P > 0.05). On the reverse, the platelet count and triacylglycerol (TAG) values were relatively higher among PTB than in TBLN cases. While the mean days of culture positivity were 11.6 days for TBLN, the mean days of culture positivity were 14.0 days for PTB. Anemia and serum lipid values showed no correlation with sputum bacilli load and time to culture positivity.Tuberculous lymphadenitis patients were well-endowed with serum lipid, immunological and nutritional status compared with PTB cases. Hence, the high incidence rate of TBLN in Ethiopia could not be explained by low peripheral immunohematological values, malnutrition, Anemia, and dyslipidemia. Further study for identifying the predictors for TBLN in Ethiopia is highly desirable.
000275650 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000275650 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000275650 650_7 $$2Other$$aEthiopia
000275650 650_7 $$2Other$$aImmunohematological values
000275650 650_7 $$2Other$$aPulmonary tuberculosis
000275650 650_7 $$2Other$$aSerum lipid
000275650 650_7 $$2Other$$aTuberculous lymphadenitis
000275650 7001_ $$aNibret, Endalkachew$$b1
000275650 7001_ $$aMunshea, Abaineh$$b2
000275650 7001_ $$aDerbie, Awoke$$b3
000275650 7001_ $$aZenebe, Yohannes$$b4
000275650 7001_ $$aTadese, Aimro$$b5
000275650 7001_ $$aBirku, Tigist$$b6
000275650 7001_ $$aTesfa, Endalamaw$$b7
000275650 7001_ $$aSinishaw, Mulusew Alemneh$$b8
000275650 7001_ $$aGetachew, Hailu$$b9
000275650 7001_ $$aGashaw, Yosef$$b10
000275650 7001_ $$aYismaw, Gizachew$$b11
000275650 7001_ $$0P:(DE-He78)547386e1dd3330f9f40321e89ec05354$$aKebede, Mihiretu$$b12$$udkfz
000275650 7001_ $$aGelaw, Baye$$b13
000275650 773__ $$0PERI:(DE-600)2091381-3$$a10.1186/s12944-023-01821-3$$gVol. 22, no. 1, p. 56$$n1$$p56$$tLipids in health and disease$$v22$$x1476-511X$$y2023
000275650 909CO $$ooai:inrepo02.dkfz.de:275650$$pVDB
000275650 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)547386e1dd3330f9f40321e89ec05354$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000275650 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000275650 9141_ $$y2023
000275650 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-09
000275650 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-09
000275650 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2022-11-09
000275650 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2022-11-09
000275650 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLIPIDS HEALTH DIS : 2022$$d2023-10-24
000275650 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-24
000275650 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-24
000275650 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-24
000275650 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-04-12T15:07:23Z
000275650 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-04-12T15:07:23Z
000275650 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2023-04-12T15:07:23Z
000275650 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-24
000275650 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-24
000275650 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-24
000275650 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-24
000275650 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-24
000275650 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000275650 980__ $$ajournal
000275650 980__ $$aVDB
000275650 980__ $$aI:(DE-He78)C020-20160331
000275650 980__ $$aUNRESTRICTED